These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 16269611)

  • 1. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
    Burger JA; Kipps TJ
    Blood; 2006 Mar; 107(5):1761-7. PubMed ID: 16269611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.
    Dewan MZ; Ahmed S; Iwasaki Y; Ohba K; Toi M; Yamamoto N
    Biomed Pharmacother; 2006 Jul; 60(6):273-6. PubMed ID: 16828253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
    Orimo A; Gupta PB; Sgroi DC; Arenzana-Seisdedos F; Delaunay T; Naeem R; Carey VJ; Richardson AL; Weinberg RA
    Cell; 2005 May; 121(3):335-48. PubMed ID: 15882617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
    Wang J; Loberg R; Taichman RS
    Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
    Burger M; Hartmann T; Krome M; Rawluk J; Tamamura H; Fujii N; Kipps TJ; Burger JA
    Blood; 2005 Sep; 106(5):1824-30. PubMed ID: 15905192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.
    Liang Z; Brooks J; Willard M; Liang K; Yoon Y; Kang S; Shim H
    Biochem Biophys Res Commun; 2007 Aug; 359(3):716-22. PubMed ID: 17559806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.
    Zeng Z; Samudio IJ; Munsell M; An J; Huang Z; Estey E; Andreeff M; Konopleva M
    Mol Cancer Ther; 2006 Dec; 5(12):3113-21. PubMed ID: 17172414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.
    Kryczek I; Wei S; Keller E; Liu R; Zou W
    Am J Physiol Cell Physiol; 2007 Mar; 292(3):C987-95. PubMed ID: 16943240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
    Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.
    Katoh H; Hosono K; Ito Y; Suzuki T; Ogawa Y; Kubo H; Kamata H; Mishima T; Tamaki H; Sakagami H; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Am J Pathol; 2010 Mar; 176(3):1469-83. PubMed ID: 20110411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
    Peled A; Klein S; Beider K; Burger JA; Abraham M
    Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.
    Kucia M; Jankowski K; Reca R; Wysoczynski M; Bandura L; Allendorf DJ; Zhang J; Ratajczak J; Ratajczak MZ
    J Mol Histol; 2004 Mar; 35(3):233-45. PubMed ID: 15339043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
    Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
    Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
    Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
    Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
    Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.